Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: No effect on endothelial adhesion properties

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 2, 2003, Pages 88-95

  Grundt, Heidi ^a   Nilsen, Dennis W T ^a,b   Mansoor, Mohammad A ^a   Hetland, Øyvind ^a   Nordøy, Arne ^c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Circulating E selectin; Circulating intercellular adhesion molecule 1; Homocysteine; Myocardial infarction; n 3 polyunsaturated fatty acids; Ultrasensitive C reactive protein

Indexed keywords

C REACTIVE PROTEIN; CORN OIL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; OMEGA 3 FATTY ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION; CELL ADHESION MOLECULES; CORN OIL; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TIME FACTORS;

EID: 0344493770     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073852     Document Type: Article

References (37)

1. Kinsella JE, Lokesh B, Stone RA: Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: Possible mechanisms. Am J Clin Nutr 1990;52:1-28.
2. GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999;354:447-455.
3. Malinow MR: Homocyst(e)ine and arterial occlusive disease. J Intern Med 1994;236:603-617.
4. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomo-cysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
5. Malinow MR, Stampfer MJ: Role of plasma homocyst(e)ine in arterial occlusive disease. Clin Chem 1994;40:857-858.
6. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvåle G: Total plasma homocysteine and cardiovascular risk profile. JAMA 1995;274:1526-1533.
7. Olszewski AO, Kilmer S, Cully MC: Fish oil decreases serum homocysteine in hyperlipemic men. Coron Artery Dis 1993;4:53-60.
8. Grundt H, Nilsen DWT, Hetland Ø, Mansoor MA, Aarsland T, Woie L: Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost 1999;81:561-565.
9. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen H, Nenseter MS: Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest 1999;29:100-108.
10. Baydas G, Yilmaz O, Celik S, Yasar A, Gursu MF: Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch Med Res 2002;33:515-519.
11. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, Farzati B, Giugliano D: Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999;281:2113-2118.
12. Welch GN, Upchurch GR Jr, Loscalzo J: Homocysteine, oxidative stress and vascular disease. Hosp Pract 1997;32:81-92.
13. Dudman NP, Temple SE, Guo XW, Fu W, Perry MA: Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999;84:409-416.
14. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J: Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-318.
15. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-17017.
16. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM: Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 2000;279:H970-H975.
17. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
18. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
19. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-434.
20. De Caterina R, Libby P: Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996;31(suppl):S57-S63.
21. Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM: Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998;18:723-731.
22. Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CR, Hjermann I: Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest 1998;28:629-635.
23. Johansen O, Seljeflot I, Hoøstmark AT, Arnesen H: The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 1999;19:1681-1686.
24. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L: Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL-cholesterol Am J Clin Nutr 2001;74:50-56.
25. Mansoor MA, Svardal AM, Ueland PM: Determination of the in vivo redox status of cysteine, cysteinglycine, homocysteine, and glutathione in human plasma. Analyt Biochem 1992;200:218-229.
26. Burstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-595.
27. Nordøy A, Bønaa KH, Nilsen H, Berge RK, Hansen JB, Ingebretsen OC: Effects of simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. J Intern Med 1998;243:163-170.
28. Fleiss JL: The design and analysis of clinical experiments. New York, Wiley, 1986.
29. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210-1216.
30. Glueck CJ, Shaw P, Lang JE, Tracy T, Sieve-Smith I, Wang Y: Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995;75:132-136.
31. Zaloga GP, Marik P: Lipid modulation and systemic inflammation. Crit Care Clin 2001;17:201-217.
32. Twisk AJ, Rutten FA, Schornagel-Hoeben K, Kraal G: The influence of dietary fat on the interaction of lymphocytes with high endothelial venules. Immunobiology 1992;186:394-409.
33. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204.
34. Collie-Duguid ESR, Wahle KWJ: Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996;220:969-974.
35. Khalfoun B, Thibault G, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapentaenoic acids inhibit human in vitro lymphocyte-endothelial cell adhesion. Transplantation 1996;62:1649-1657.
36. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P: The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994;14:1829-1836.
37. Hwang S-J, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk In Communities (ARIC) Study. Circulation 1997;96:4219-4225.